JAKARTA – PT Brigit Biofarmaka Teknologi Tbk (OBAT) has commenced operations at a pharmaceutical plant with a production capacity of 750,000 capsules per day in Sukoharjo, Central Java. This increased production is expected to drive sales growth in the coming year.

Toufin Noor Prambudi, Corporate Secretary of OBAT, stated that the new factory is located on a 1,060 m² plot with a two-storey building covering 1,500 m². "It will produce a range of herbal supplement products," he said on Wednesday (19/2).

The newly launched factory (19/2) will produce supplements in various packaging, including strip, blister, and bottle-packaged capsules, as well as liquid medicines in sachets and bottles. The facility is also equipped with supporting infrastructure, including physics, chemistry, and microbiology laboratories.

In addition to capsule-packaged herbal production, OBAT is projecting the new plant will also produce 1,000 litres of liquid preparations per day.

The management of OBAT claims that this factory will significantly contribute to future sales. “With projection of up to threefold growth,” added Toufin.

During its IPO, earlier this year on January 13, 2025, OBAT management stated that the pharmaceutical plant is expected to contribute IDR 250 billion in annual revenue.

On the same occasion, management anticipates doubling its revenue in 2024, from the 2023 realisation of IDR 53 billion. (LK/KR/ZH)